Another recent study found evidence to propose that AIP can be considered as a novel and better biomarker for obesity, as subjects in the higher quartiles of AIP all had a significantly increased risk of obesity compared with those in the lowest quartile in a Chinese population [33]. The gene discussed is AIP; the disease is obesity due to melanocortin 4 receptor deficiency.